NeuroSense Therapeutics
phase a study design | NeuroSense Therapeutics
Company
Deck Type
Sector
Industry
Deck date
June 2023
Slide
16 of 34
Related slides by other companies
Renovacor
SPAC
October 2022
proposed phase i clinical study design for | Renovacor
Ocuphire Pharma
Results
October 2022
topical eyedrops in clinical development for | Ocuphire Pharma
RenovoRx
IPO
August 2021
designed for success one phase trial to approval pivotal tiger pac phase study schema currently enrolling | RenovoRx
Aeglea BioTherapeutics
Investor Presentation
October 2023
combination programs summary wot | Aeglea BioTherapeutics
Other recent decks by NeuroSense Therapeutics
See all presentations (4 decks)
Investor Presentation
October 2024
Investor Presentation
January 2024
Investor Presentation
December 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights